143 related articles for article (PubMed ID: 37945138)
1. Hepatocellular Carcinoma Surveillance: Evidence-Based Tailored Approach.
Koo E; Singal AG
Surg Oncol Clin N Am; 2024 Jan; 33(1):13-28. PubMed ID: 37945138
[TBL] [Abstract][Full Text] [Related]
2. Early detection of hepatocellular carcinoma: roadmap for improvement.
Melendez-Torres J; Singal AG
Expert Rev Anticancer Ther; 2022 Jun; 22(6):621-632. PubMed ID: 35514249
[TBL] [Abstract][Full Text] [Related]
3. Provider Attitudes Toward Risk-Based Hepatocellular Carcinoma Surveillance in Patients With Cirrhosis in the United States.
Kim NJ; Rozenberg-Ben-Dror K; Jacob DA; Rich NE; Singal AG; Aby ES; Yang JD; Nguyen V; Pillai A; Fuchs M; Moon AM; Shroff H; Agarwal PD; Perumalswami P; Chandna S; Zhou K; Patel YA; Latt NL; Wong R; Duarte-Rojo A; Lindenmeyer CC; Frenette C; Ge J; Mehta N; Yao F; Benhammou JN; Bloom PP; Leise M; Kim HS; Levy C; Barnard A; Khalili M; Ioannou GN
Clin Gastroenterol Hepatol; 2022 Jan; 20(1):183-193. PubMed ID: 32927050
[TBL] [Abstract][Full Text] [Related]
4. Emerging Tools for Hepatocellular Carcinoma Surveillance.
Singal AG; Reig M; Villanueva A
Am J Gastroenterol; 2022 Dec; 117(12):1948-1951. PubMed ID: 36114768
[TBL] [Abstract][Full Text] [Related]
5. Noncontrast magnetic resonance imaging versus ultrasonography for hepatocellular carcinoma surveillance (MIRACLE-HCC): study protocol for a prospective randomized trial.
An C; Kim DY; Choi JY; Han KH; Roh YH; Kim MJ
BMC Cancer; 2018 Sep; 18(1):915. PubMed ID: 30249190
[TBL] [Abstract][Full Text] [Related]
6. Blood-based biomarkers for hepatocellular carcinoma screening: Approaching the end of the ultrasound era?
Parikh ND; Tayob N; Singal AG
J Hepatol; 2023 Jan; 78(1):207-216. PubMed ID: 36089157
[TBL] [Abstract][Full Text] [Related]
7. Hepatocellular carcinoma surveillance - utilization, barriers and the impact of changing aetiology.
Huang DQ; Singal AG; Kanwal F; Lampertico P; Buti M; Sirlin CB; Nguyen MH; Loomba R
Nat Rev Gastroenterol Hepatol; 2023 Dec; 20(12):797-809. PubMed ID: 37537332
[TBL] [Abstract][Full Text] [Related]
8. Hepatocellular carcinoma surveillance: An evidence-based approach.
Harris PS; Hansen RM; Gray ME; Massoud OI; McGuire BM; Shoreibah MG
World J Gastroenterol; 2019 Apr; 25(13):1550-1559. PubMed ID: 30983815
[TBL] [Abstract][Full Text] [Related]
9. Biomarkers: evaluation of clinical utility in surveillance and early diagnosis for hepatocellular carcinoma.
Song P; Tang Q; Feng X; Tang W
Scand J Clin Lab Invest Suppl; 2016; 245():S70-6. PubMed ID: 27438343
[TBL] [Abstract][Full Text] [Related]
10. Comparison of biannual ultrasonography and annual non-contrast liver magnetic resonance imaging as surveillance tools for hepatocellular carcinoma in patients with liver cirrhosis (MAGNUS-HCC): a study protocol.
Kim HA; Kim KA; Choi JI; Lee JM; Lee CH; Kang TW; Ku YM; Lee SL; Park YS; Yoon JH; Kim SH; Choi MH
BMC Cancer; 2017 Dec; 17(1):877. PubMed ID: 29268722
[TBL] [Abstract][Full Text] [Related]
11. Surveillance for hepatocellular carcinoma: how can we do better?
Hassett M; Yopp AC; Singal AG
Am J Med Sci; 2013 Oct; 346(4):308-13. PubMed ID: 23426089
[TBL] [Abstract][Full Text] [Related]
12. Hepatocellular carcinoma surveillance in patients with non-alcoholic fatty liver disease.
Seif El Dahan K; Daher D; Singal AG
Clin Mol Hepatol; 2023 Feb; 29(Suppl):S207-S219. PubMed ID: 36103899
[TBL] [Abstract][Full Text] [Related]
13. The Future Role of Abdominal US in Hepatocellular Carcinoma Surveillance.
Mendiratta-Lala M; Fetzer D; Kamaya A; Parikh ND; Singal AG
Radiology; 2024 May; 311(2):e232624. PubMed ID: 38742973
[TBL] [Abstract][Full Text] [Related]
14. Patient-, Provider-, and System-Level Barriers to Surveillance for Hepatocellular Carcinoma in High-Risk Patients in the USA: a Scoping Review.
Beal EW; Owen M; McNamara M; McAlearney AS; Tsung A
J Gastrointest Cancer; 2023 Jun; 54(2):332-356. PubMed ID: 35879510
[TBL] [Abstract][Full Text] [Related]
15. Doylestown Plus and GALAD Demonstrate High Sensitivity for HCC Detection in Patients With Cirrhosis.
Singal AG; Tayob N; Mehta A; Marrero JA; Jin Q; Lau J; Parikh ND
Clin Gastroenterol Hepatol; 2022 Apr; 20(4):953-955.e2. PubMed ID: 33864933
[TBL] [Abstract][Full Text] [Related]
16. Current and Emerging Tools for Hepatocellular Carcinoma Surveillance.
Adeniji N; Dhanasekaran R
Hepatol Commun; 2021 Dec; 5(12):1972-1986. PubMed ID: 34533885
[TBL] [Abstract][Full Text] [Related]
17. Meta-analysis: surveillance with ultrasound for early-stage hepatocellular carcinoma in patients with cirrhosis.
Singal A; Volk ML; Waljee A; Salgia R; Higgins P; Rogers MA; Marrero JA
Aliment Pharmacol Ther; 2009 Jul; 30(1):37-47. PubMed ID: 19392863
[TBL] [Abstract][Full Text] [Related]
18. Alpha-Fetoprotein Detection of Hepatocellular Carcinoma Leads to a Standardized Analysis of Dynamic AFP to Improve Screening Based Detection.
Bird TG; Dimitropoulou P; Turner RM; Jenks SJ; Cusack P; Hey S; Blunsum A; Kelly S; Sturgeon C; Hayes PC; Bird SM
PLoS One; 2016; 11(6):e0156801. PubMed ID: 27308823
[TBL] [Abstract][Full Text] [Related]
19. International Liver Cancer Association (ILCA) white paper on hepatocellular carcinoma risk stratification and surveillance.
Singal AG; Sanduzzi-Zamparelli M; Nahon P; Ronot M; Hoshida Y; Rich N; Reig M; Vilgrain V; Marrero J; Llovet JM; Parikh ND; Villanueva A
J Hepatol; 2023 Jul; 79(1):226-239. PubMed ID: 36854345
[TBL] [Abstract][Full Text] [Related]
20. Hepatocellular Carcinoma Screening and Surveillance: Practice Guidelines and Real-Life Practice.
Zhao C; Nguyen MH
J Clin Gastroenterol; 2016 Feb; 50(2):120-33. PubMed ID: 26583266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
